In participants with high UTI risk at baseline ( n = 516 ) , the incidence of clinically defined UTI was lower with cranberry capsules than with placebo ( 62.8 vs 84.8 per 100 person-years at risk , P = .04 ) ; the treatment effect was 0.74 ( 95 % confidence interval ( CI ) = 0.57-0 .97 ) .